more focus on treating Clostridium difficile

June 2013

You'll see more focus on treating Clostridium difficile.

These GI infections are more common and harder to treat...partly due to a more virulent strain. Widespread reliance on hand gels might be adding to the problem because they don't kill C. diff spores.

The risk of recurrence is up to 25% after the first episode...and up to 65% after the second episode.

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber Insights: APRN includes:

Cutting-edge advice about new medications and how they fit into practice
Unbiased, evidence-based, 100% free of financial support from the pharma industry written by your peers
Side-by-side comparisons of drugs by class or disease state, plus FAQs, pros/cons, and simple recommendations

Subscribe Today!

Already a subscriber? Log in

Volume pricing available. Get a quote

Infectious Diseases more focus on treating Clostridium difficile
Smoking Cessation New labels for OTC nicotine replacement therapy will no longer tell patients they have to stop smoking first
Supplements the safety and benefits of L-carnitine
Pregnancy Diclegis (dye-CLEE-gis), a "new" Rx drug for morning sickness
Insomnia Are non-benzodiazepine hypnotics (zolpidem, etc) really safer than benzos (temazepam, etc) for seniors with insomnia
Gastroenterology experts following new guidelines for gastroparesis
Diabetes more emphasis on preventing and treating hypoglycemia in patients with type 2 diabetes
Dermatology two new topical OTC anti-itch products, Allegra Cooling Relief and Allegra Intensive Relief
Anticoagulants tPA (alteplase) for ischemic strokes in patients on oral antithrombotics (warfarin, etc)
Cardiology whether it's okay for patients on clopidogrel (Plavix, etc) to take a PPI
Women's Health Osphena (os-FEE-nah, ospemifene) for women with pain during intercourse due to menopause

more focus on treating Clostridium difficile

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Table of Contents